"Shockwave begins study of IVL catheter for coronary artery lesions" was originally created and published by Medical Device ...

Johnson & Johnson MedTech‘s  Medical announced today that it initiated a study evaluating its Javelin coronary IVL catheter.

The device is differentiated from other Shockwave products, and rival catheters from Abbott and Boston Scientific, because it ...

Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...

Elixir trails J&J’s Shockwave but has outpaced Bolt Medical to the European market with its mechanical IVL system.

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular lithotripsy (IVL) system, positioning ...

Results from the company’s trial of 3,500 patients found that disease burden was higher in men but women were at higher risk of MACE.

Boston Scientific (NYSE: BSX) announced on social media that it completed its previously announced acquisition of Bolt ...

Last month, Shockwave introduced the Javelin Peripheral IVL Catheter in the US market, targeting peripheral artery disease. "Shockwave begins study of IVL catheter for coronary artery lesions" was ...